ICI201
CICI201Y001
Phase 1 small_molecule terminated
Quick answer
ICI201 for Relapsed/Refractory Multiple Myeloma is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Relapsed/Refractory Multiple Myeloma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated